CME Sponsor:
CME Outfitters, LLC

Location: Online Activity

Course Directors/Instructors:
Moderator
Michael K. Racke, MD
Professor and Chairman in Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
Ohio State University Medical Center
Columbus, OH

Faculty Information
Benjamin M. Greenberg, MD, MHS
Director, Transverse Myelitis and Neuromyelitis
Optica Program
Director, Pediatric Demyelinating Disease Program
Deputy Director, Multiple Sclerosis Program
Cain Denius Scholar in Mobility Disorders
University of Texas Southwestern Medical Center
Dallas, TX

Deborah M. Miller, PhD, LISW
Director of Comprehensive Care at the Mellen Center
for Multiple Sclerosis Treatment and Research
Department of Neurology
Associate Professor of Medicine, Cleveland Clinic
Lerner College of Medicine
The Cleveland Clinic Foundation
Cleveland, OH

Number of Credits:
1.0 AMA PRA Category 1 Credit™

Registration Fee: Free

More Info

Detailed Description:
With increased focus on individualized treatment in multiple sclerosis, the importance of patient-reported outcomes (PRO) is evident. While PRO assessments are not replacements for professionally moderated questionnaires and more formal measurements (e.g., the EDSS or MRI imaging), they can serve as an invaluable resource that fosters stronger physician-patient relationships, encourages patients to increase ownership in managing their disease, and addresses patient concerns directly. However, clinicians do not consistently use PRO tools, and questions about their utility remain. In this neuroscienceCME Live and On Demand activity, expert faculty will review current evidence concerning the usefulness and implementation of PRO tools in clinical practice and discuss the value of integrating PRO data to refine individual treatment and increase patient satisfaction with the quality of both their care and their lives.

 Learning Objectives:
At the end of this CE activity, participants should be able to:
  • Evaluate emerging evidence for the utility of patient-reported outcome (PRO) measures and identify methods for application to clinical practice.
  • Improve assessment of disease status in patients with multiple sclerosis by using validated, patient-reported outcomes tools that are supported by evidence and available guidelines.
  • Integrate patient-reported outcomes into individual care plans to refine treatment and improve quality of life for patients with MS across the continuum of care.
The following learning objectives pertain only to those requesting CNE credit:
  • Evaluate emerging evidence for the utility of patient-reported outcome (PRO) measures in clinical practice.
  • Identify validated, patient-reported outcome measures that are supported by available guidelines for assessment of disease status in patients with MS.
  • Review the value of results from patient-reported outcome measures to improve quality of life for patients with MS by optimizing individual care plans across the continuum of care.
Intended Audience:
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other healthcare professionals with an interest in multiple sclerosis.